Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36036 |
CAY10786
GPR52 antagonist-1 |
GPR | Endocrinology/Hormones; GPCR/G Protein |
CAY10786 (GPR52 antagonist-1) 是 G 蛋白偶联受体 52 (GPR52, IC50 = 0.63 μM) 的拮抗剂。 | |||
T0719 |
Tetrabenazine
Xenazine,丁苯那嗪,Ro 1-9569 |
Others; Dopamine Receptor; Monoamine Transporter | GPCR/G Protein; Membrane transporter/Ion channel; Neuroscience; Others |
Tetrabenazine (Ro 1-9569) 是 VMAT 抑制剂,用作抗精神病药和治疗各种运动障碍。 | |||
T39479 |
Rovanersen
WVE-120101,Rovanersen |
||
Rovanersen (WVE-120101) is an antisense oligonucleotide that can be used for huntington’s disease research. | |||
T26878 |
BN-82451 HCl
BN 82451B,BN 82451,BN-82451,BN82451B,BN-82451B,BN82451 |
||
BN-82451, a cyclooxygenase inhibitor, is used potentially for the treatment of Huntington’s disease. | |||
T39166 |
Tominersen
IONIS-HTTRx,RG6042 |
||
Tominersen (RG6042) is a second-generation 2′-O-(2-methoxyethyl) antisense oligonucleotide that targets huntingtin protein (HTT) mRNA and potently suppresses HTT production. Tominersen can be used for the research of Huntington’s disease. | |||
T60824 | Dyrk1A-IN-3 | ||
Dyrk1A-IN-3 (Compound 8b) 是双特异性酪氨酸调节激酶 1A (DYRK1A) 的高选择性抑制剂。Dyrk1A-IN-3与 DYRK1A 结合具有高结合亲和力,IC50值为76 nM。Dyrk1A-IN-3可用于研究神经退行性疾病,例如,阿尔茨海默病、亨廷顿病和帕金森病等。 | |||
T61063 | SEN177 | ||
SEN177 在亨廷顿病的研究中显示出潜力。它是谷氨酰胺环化酶 (QPCT) 的有效抑制剂,对谷氨酰胺肽环转移酶 (QPCTL) 的 IC50值为 0.013 μM。SEN177 对人谷氨酰胺环化酶 (hQC) 的 Ki 值为 20 nM。SEN177 显著降低了突变 HTT 寡聚化的早期阶段,并降低了具有 Q80 聚集体的神经元的百分比。 | |||
T74881 | FITC-labeled Tominersen | ||
FITC-labeled Tominersen 是 FITC 标记的 Tominersen。Tominersen (RG6042) 是第二代 2′-O-(2-甲氧基乙基) 反义寡核苷酸,靶向亨廷蛋白 (HTT) mRNA,有效抑制 HTT 的合成。Tominersen 能在小鼠中提高存活率并减少脑萎缩。Tominersen 可用于亨廷顿病 (HD) 的研究。 | |||
T73683 |
AC-VEID-CHO TFA
|
||
AC-VEID-CHO (TFA) 是一种源自多肽的半胱天冬酶抑制剂,针对Caspase-6、Caspase-3和Caspase-7展示出优异的抑制效果,其IC50值分别为16.2 nM、13.6 nM和162.1 nM。该化合物常用于研究阿尔茨海默病、亨廷顿病等神经退行性疾病。 | |||
T37791 |
A-971432
|
||
A-971432 is a sphingosine-1-phosphate receptor 5 (S1P5) agonist that is selective for S1P5 over S1P1 and S1P3 (IC50s = 0.006, 0.362, and >10 µM, respectively). It inhibits forskolin-induced cAMP production in CHO cells expressing S1P5 (EC50 = 4.1 nM). A-971432 (1 µM) increases electrical resistance of hCMEC/D3 cells in an in vitro blood-brain barrier model, indicating enhanced barrier integrity, and attenuates blood-brain barrier leakage in an R6/2 transgenic mouse model of Huntington’s ... | |||
T83669 |
PMX-53 TFA
AcPhe-[Orn-Pro-D-Cyclohexylalanine-Trp-Arg],AcF-[OPdChaWR],3D53 |
||
PMX-53是一种大环型补体5a (C5a) 类肽模拟物及C5a受体的拮抗剂(IC50 = 0.3 µM)。它能抑制C5a诱导的人类分离性多形核白细胞(PMNs)中的髓过氧化物酶(MPO)分泌。在大鼠腹膜亚瑟斯反应模型中,PMX-53(10 mg/kg, p.o.)能够抑制血管渗漏、多形核白细胞浸润以及腹膜TNF-α和IL-6的产生。在3-硝基丙酸(3-NP)诱导的亨廷顿病大鼠模型中,它能减少体重损失和厌食,抑制纹状体退化。PMX-53(3 mg/kg)还能在ApoE-/-小鼠中减小动脉粥样硬化斑块大小和脂质含量。 |